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ABSTRACT   BACKGROUND AND AIM: Helicobacter pylori (H. pylori)   infection induces 
inflammation of the gastric mucosa and leads to erosions, gastro-duodenal mucosa atrophy, 
and intestinal metaplasia. The Kyoto classification diagnoses H. pylori  infection via endoscopic 
findings. We aimed to clarify the role of the Kyoto classification in diagnosing H. pylori  infection 
and histologic gastritis in young Japanese individuals.
   METHODS: From1031 consecutive subjects aged ≤29 years who underwent esophago-
gastroduodenal endoscopy at our two hospitals from 2010 to 2017, 220 were selected for 
participation in the present study. Endoscopic biopsy specimens from the antrum and corpus 
were used to investigate H. pylori  infection and histology. Endoscopic and histological 
interpretations were based on the Kyoto classification and updated Sydney System. H. pylori  
infection was confirmed by histology and Giemsa or Gimenez staining. 
   RESULTS: Endoscopic findings were normal in 103 cases. Atrophy was found in 56 cases; 
diffuse redness, in 45 cases; nodularity, in 38 cases; and mucosal swelling, in 34 cases. The 
infection rate was 30.9% (68/220). In total, 67 subjects with H. pylori -positive endoscopic 
findings and confirmed as H. pylori -positive had histologic gastritis of the antrum and corpus. In 
contrast, of 153 subjects with H. pylori -negative endoscopic findings only 1 was subsequently 
confirmed to be H. pylori  positive. Among the 67 subjects with H. pylori -positive endoscopic 
findings, 23 (34.3%) presented with histological atrophic gastritis of the corpus and 6 (9.0%) 
with intestinal metaplasia.
〈Regular Article〉
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such as gastric cancer, peptic ulcer, and atrophic 
gastritis are common in those age groups. Earlier 
testing and treatment for H. pylori infection are 
required to prevent development of gastrointestinal 
diseases, including gastric cancer10，11）; however, 
little is known about endoscopic and histological 
findings in young subjects.
   The aim of this study was to evaluate endoscopic 
and histological findings based on the Kyoto 
classification among young subjects in Japan. 
SUBJECTS AND METHODS
Patients
   In total, 1,031 consecutive outpatients under 
the age of 29 years old who underwent esophago-
gastroduodenal endoscopy at two hospitals 
(General Medical Center and Kawasaki Medical 
Hospital) from 2010 to 2017 were eligible for 
inclusion in this study. From those, we selected 
220 subjects in whom complete retrospective 
observation of the whole stomach was conducted 
to evaluate endoscopic findings as per the Kyoto 
classification and at least two biopsy specimens 
(one from the greater curvature of the antrum and 
one from the greater curvature of the corpus) were 
obtained to evaluate status of H. pylori infection 
and histologic gastritis. The reasons for endoscopy 
included precise examination of gastrointestinal 
symptoms (n = 187, 85.0%), health-care check (n 
= 6, 2.7%) and others (n = 27, 12.3%). The main 
gastrointestinal symptoms were epigastralgia (n 
= 80, 36.4%), abdominal pain in other areas (n 
= 27, 12.3%), vomiting/nausea (n = 21, 9.5%), 
INTRODUCTION
   Since 1983, when Warren and Marshall１） 
provided the first description of Helicobacter pylori 
(H. pylori) , strong evidence has accumulated that 
H. pylori infection plays an important role in the 
pathogenesis of chronic gastritis, peptic ulcers, 
and gastric cancer２－４）. H. pylori infection can 
lead to development of histologic gastritis and 
results in multiple endoscopic findings that include 
redness, erosions, atrophy, enlarged fold, and 
nodularity３，５，６）.
   A standardized classification of gastritis was 
proposed by a working group at the World Congress 
of Gastroenterology in Sydney in 1990 (Sydney 
System)７）, and this classification has been adopted 
as the updated Sydney System８）. Thus, endoscopic 
and histologic gastritis has been classified in recent 
years as per the updated Sydney System. Since 
February 2013, all H. pylori-positive subjects have 
been cured under the national health insurance 
in Japan, however esophago-gastroduodenal 
endoscopy is required before treatment to exclude 
possible related diseases e.g. gastric cancer, peptic 
ulcers, and reflux esophagitis. In addition, the 
test for H. pylori infection is indicated only for 
patients suspected to be H. pylori-positive by 
endoscopy. Therefore, it is important to evaluate 
H. pylori infection by endoscopy. We have recently 
established the Kyoto classification of gastritis to 
diagnose H. pylori infection based on endoscopy in 
the Japanese population９）. Most reported studies 
on H. pylori infection and gastritis have focused on 
middle aged and elderly populations, as diseases 
   CONCLUSIONS: Our findings show that H. pylori  infection is strongly associated with 
endoscopic and histologic gastritis in young subjects and both H. pylori  infection and histologic 
gastritis can be evaluated endoscopically based on the Kyoto classification. Furthermore, 
prompt H. pylori  eradication may prevent gastric cancer development given the high prevalence 
of atrophic gastritis and intestinal metaplasia in young Japanese individuals.
 doi：10.11482/KMJ-E201945043　(Accepted on June 13, 2019)
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upper abdominal discomfort (n = 16, 7.3%), and 
heartburn (n = 9, 4.1%). Exclusion criteria included 
use of certain medications, including nonsteroidal 
anti-inflammatory drugs (NSAIDs), antacids, H２
-receptor antagonists, proton pump inhibitors, and 
antibiotics in the month preceding endoscopy, a 
history of gastric surgery, pregnancy, a history 
of systemic diseases such as collagen disease, 
inflammatory bowel disease and eosinophilic 
gastroenteritis, and a history of treatment to cure H. 
pylori. 
   The study was approved by the ethics committee 
of our university (Approval number: 2965) and the 
study was conducted according to the principles 
of the Declaration of Helsinki with the study 
participants’ understanding and consent.
 
Endoscopic findings
   Endoscopy was performed for all patients in 
the absence of any pre-medication and after an 
overnight fast. Endoscopic findings were evaluated 
by three endoscopists (M.S, T.K, and K.H) who 
were blinded to the subjects’ symptoms, laboratory 
data, histological reports of biopsy specimens and H. 
pylori infection status as per the classification criteria 
of the Kyoto classification (Table 1, Fig. 1)９）. Any 
disagreement was resolved by joint discussion to 
reach consensus. The degree of endoscopic atrophic 
change of the corpus was classified into six grades 
(from C1 (none) to O3 (extremely severe) as per the 
Kimura-Takemoto classification12）. 
Assessment of histological gastritis and H. pylori 
infection
   Gastric biopsy specimens were obtained during 
endoscopy and histologically assessed for all 
patients. At least two biopsy specimens were 
obtained during endoscopy from each patient. One 
specimen was obtained from the greater curvature of 
the antrum and another specimen was obtained from 
the greater curvature of the mid-corpus. Specimens 
were fixed in 10% buffered formalin, embedded 
in paraffin, sliced into 4-μm sections, and stained 
with hematoxylin and eosin (H&E) for histologic 
examination and Giemsa stain or Gimenez staining 
for H. pylori identification (Fig. 2). All Giemsa- 
and Gimenez-stained and H&E-stained biopsy 
specimens were reviewed by trained pathologists 
(YM and TA) who were blinded to the subjects’  
data. Histologic interpretation was based on the 
updated Sydney System. Inflammation of gastric 
mucosa was defined as presence of inflammatory 
infiltrates comprising neutrophils, lymphocytes, and 
plasma cells. Mucosal atrophy was defined as loss 
of glandular tissue. Inflammation, mucosal atrophy, 
and intestinal metaplasia were classified based on 
their degree of severity into four categories: none, 
mild, moderate, and severe. 
   H. pylori infection status was determined by 
Giemsa or Gimenez staining along with presence 
of histological inflammation. Moderate or higher 
degree of inflammation was regarded as significant 
infiltration of H. pylori infection. Subjects were 
determined to be uninfected if both investigations 
(H. pylori by Giemsa or Gimenez staining and 
histological inflammation over moderate) were 
negative. 
RESULTS
   The subjects in this study included 95 males and 
125 females, with a mean age of 21.7 years (range: 
13-29 years) for males and 22.8 years (range: 10-29 
years) for females.
   Endoscopic diagnosis of 220 subjects showed 103 
(46.8%) were normal, 67 (30.5%) had gastritis, 19 
(8.6%) had duodenal ulcer, and 4 (1.8%) had gastric 
ulcer. 
   Based on the Kyoto classification, atrophy was 
found in 56 (25.4%), diffuse redness in 45(20.5%), 
nodularity in 38 (17.3%), mucosal swelling in 34 
(15.5%), red streak in 20 (9.1%), fundic gland polyp 
in 18 (8.2%), raised erosion in 10 (4.5%), hematin in 
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9 (4.1%), enlarged fold in 5 (2.3%), and depressive 
erosion in 3 (1.4%); the remaining subjects were 
normal. Among the H. pylori-positive subjects the 
main endoscopic findings were atrophy 56 (83.6%), 
diffuse redness 45 (67.2%), nodularity 38 (56.7%), 
mucosal swelling 34 (50.7%), and enlarged fold 5 
(7.5%); one case had normal endoscopic findings. 
Among the H. pylori-negative subjects, 103 (67.3%) 
had normal findings, 20 (13.1%) had red streak, 
18 (11.7%) had fundic gland polyp, 10 (6.5%) had 
raised erosion, 9 (5.9%) had hematin, and 3 (2.0%) 
depressive erosion (Table 1). According to the Kyoto 
Fig. 1. Typical endoscopic findings of H. pylori-positive subjects. 
(a) Atrophy: Atrophy is recognized as a region discolored to a diffuse white tone, and the atrophy boundary exhibits 
C3. 
(b) Diffuse redness: Diffuse redness is observed over the entire field of view of greater curvature of the corpus with 
uniform redness and continuous expansion. 
(c) Mucosal swelling: Mucosal swelling is seen as soft and thick irregularities. 
(d) Nodularity: Nodularity is observed as uniform small granular elevation, shaped like cobblestones and highly 
concentrated in the antrum.
Table 1. Endoscopic findings of 220 cases (number of findings 
includes duplicate cases with multiple findings in one case) in H. 
pylori positive and negative young subjects 
H. pylori-positive endoscopic findings (N = 67)
　Atrophic gastritis (more than C2) N = 56
　Diffuse redness N = 45
　Nodularity N = 38
　Mucosal swelling N = 34
　Enlarged fold, tortuous fold N = 5
　Xanthoma N = 1
H. pylori-negative endoscopic findings (N=153)
　Normal N = 103
　Red streak N = 20
　Fundic gland polyp N = 18
　Raised erosion N = 10
　Hematin N = 9
　Depressive erosion N = 3
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Table 2. Sensitivity and specificity of the diagnosis for H. pylori 
infection as per Kyoto classification in young subjects
H. pylori infection via 
biopsy specimens
positive negative Total
H. pylori infection via 
the Kyoto classification
positive 67 0 67
negative 1 152 153
Total 68 152 220
Sensitivity　67/68 = 98.5%
Specificity　152/152 = 100%
Positive predictive value　67/67 = 100%
Negative predictive value　152/153 = 99.3%
Accuracy　219/220 = 99.5%
classification, endoscopic findings are classified 
into two categories, H. pylori-positive or H. pylori-
negative. All subjects with 67 H. pylori-positive 
endoscopic findings as per the Kyoto classification, 
were histologically confirmed to have H. pylori 
infection. In contrast, among the 153 subjects with 
H. pylori-negative endoscopic findings, H. pylori 
infection was subsequently confirmed in 1 subject. 
In total, 68 of 220 subjects (32 females; mean age 
22.7 years) were diagnosed as being H. pylori-
positive and 152 of subjects (93 females; mean 
age 22.1 years) as being H. pylori-negative by 
histological examination using Giemsa or Gimenez 
staining. Therefore, the endoscopic findings using 
the Kyoto classification had 98.5% sensitivity and 
100% specificity for H. pylori infection (Table 2).
   Among the subjects with H. pylori-positive 
endoscopic findings as per the Kyoto classification, 
Fig. 2. Histologic findings of H. pylori positive subjects.
(a)Moderate inflammation of the antrum: Pyloric gland mucosa that exhibits moderate neutrophil infiltration and lymphoid cell 
infiltration. (Original magnification X200)
(b)Moderate inflammation of the corpus: Fundic gland mucosa that exhibits moderate neutrophil infiltration and lymphoid cell 
infiltration. (Original magnification X200)
(c)Atrophy of the corpus: Advanced chronic inflammatory cell infiltration can be seen, fundic gland has decreased due to atrophy. 
(Original magnification X200)
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the histological findings of the antrum revealed 
mononuclear cell infiltration in all cases; 3 (4.5%) 
mild, 38 (56.7%) moderate, 26 (38.8%) severe, 
mucosal atrophy in 68.7%: 39 (58.2%) mild, 4 
(6.0%) moderate, 3 (4.5%) severe and intestinal 
metaplasia in 5 (7.5%): 3 mild, 2 moderate. 
Histological gastritis of the corpus revealed 
mononuclear cell infiltration in 97% cases; 14 
(20.9%) mild, 37 (55.2%), moderate, 14 (20.9%) 
severe, mucosal atrophy in 34.3%: 19 (28.4%) mild, 
2 (3.0%) moderate, 2 (3.0%) severe, and intestinal 
metaplasia was noted in 2 subjects (3.0%) (Table 
3). Among these cases, one patient presented with 
histologic intestinal metaplasia in both the antrum 
and the corpus. Among the subjects with H. pylori-
negative endoscopic findings as per the Kyoto 
classification, the histological findings of the 
antrum revealed mild mononuclear cell infiltration 
in 10 (6.5%), mild atrophy in one (0.7%), and mild 
intestinal metaplasia in one (0.7%) cases. In the 
corpus, mononuclear cell infiltration was found in 
2.6% of cases: 3 (1.9%), mild; 1 (0.7%), severe; and 
1 (0.7%), mild atrophy. No intestinal metaplasia was 
noted (Table 3). 
   In addition to the histologic examination, H. pylori 
infection diagnostic tests were also administered 
to 35 of 220 cases; 15 received the rapid urease 
tests, 15 the urease breath test, and 10 the serum 
anti-H. pylori IgG antibody test. The results of these 
diagnostic tests matched the histological diagnoses.
  
DISCUSSION
   Our study has two key messages. First, the 
Kyoto classification is a useful method to diagnose 
H. pylori infection and histologic gastritis based 
on endoscopic findings among young Japanese 
subjects. Second, there is a high prevalence of 
atrophic gastritis in H. pylori-positive young 
Japanese patients. Therefore, early diagnosis and 
prompt curative therapy for H. pylori infection are 
required to prevent development of gastric cancer in 
our population.
   The updated Sydney system８） is useful to 
diagnose and classify gastritis, however, this 
classification system was not established to diagnose 
H. pylori infection and to evaluate the effect of H. 
pylori treatment and associated risk of gastric cancer 
based on endoscopic findings. In addition, there are 
Table 3. Histologic findings of the antrum and corpus in H. pylori positive and negative young 
subjects.
Histologic findings in H. pylori-positive endoscopic findings
Antrum Corpus
Feature I A IM I A IM
Grade none 0 21 62 2 44 65
mild 3 39 3 14 19 2
moderate 38 4 2 37 2 0
severe 26 3 0 14 2 0
Total 67 67 67 67 67 67
Histologic findings in H. pylori-negative endoscopic findings
Antrum Corpus
Feature I A IM I A IM
Grade none 143 152 152 149 152 153
mild 10 1 0 3 1 0
moderate 0 0 0 0 0 0
severe 0 0 1 1 0 0
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several problems in the updated Sydney system. 
Several endoscopic findings such as exudative, 
redness, and edema are difficult to diagnose 
objectively based on endoscopic observations. In 
addition, nodularity is included as an endoscopic 
finding but the diagnosis of nodular gastritis is not 
included in the classification of gastritis. Nodular 
gastritis is important as it represents a high risk 
of gastric cancer in our population13）. Recently 
we developed the Kyoto classification of gastritis 
based on endoscopic characteristics of H. pylori 
infection-associated gastritis that allows grading of 
endoscopically visible risk factors for development 
of gastric cancer９）. This classification system 
divides the endoscopic findings into three groups: 
H. pylori-negative (no gastritis), current H. pylori 
infection (active gastritis), and previously infected 
with H. pylori (inactive gastritis). This including 
scoring five parameters of gastritis (atrophy, 
intestinal metaplasia, enlarged folds, nodularity, 
and diffuse redness. Pathological reporting systems, 
such as the Sydney system７）, the Houston-updated 
version８）, and the operative link on gastritis 
assessment (OLGA) system14）, are widely used to 
evaluate gastritis severity and the risk of gastric 
cancer15）. Although pathological evaluation of 
biopsy specimens may be useful in identification 
of patients at risk for gastric cancer, biopsy has 
associated risk of gastrointestinal bleeding, 
especially in patients taking antiplatelet drugs and 
anticoagulants, and is also an expensive procedure. 
In addition, pathological findings are limited to the 
information provided by the biopsy specimen and do 
not provide information about the whole stomach.
   This study is the first report demonstrating that 
the Kyoto classification of gastritis is useful to 
evaluate H. pylori infection and histologic gastritis 
in young subjects. Previously multiple studies have 
demonstrated that characteristic endoscopic findings 
such as atrophy of the corpus, intestinal metaplasia, 
enlarged folds, nodularity, and diffuse redness 
are closely related to H. pylori infection３，５，６）; 
however, these reports have focused on the elderly 
population. The prevalence of those endoscopic 
findings, especially atrophic change and intestinal 
metaplasia increases with advancing age16－18）. 
Therefore, it is easier to diagnose H. pylori infection 
and the presence of histologic gastr i t is  by 
endoscopic findings in older subjects. In addition, 
earlier curative treatment for H. pylori may be 
more effective prevention of gastric cancer19）, 
and therefore is important for the young Japanese 
population.
   The first recognizable characteristic of endoscopic 
findings was atrophy of the corpus; 56 of 68 (82.4%) 
H. pylori-positive subjects showed atrophy of the 
corpus and 4 showed severe atrophic gastritis. 
In addition, histological study biopsy specimens 
showed atrophic gastritis of the corpus and intestinal 
metaplasia in 35.3% (24/68) and 8.8% (6/68) of 
H. pylori-positive subjects, respectively. Intestinal 
metaplasia and atrophic gastritis are closely related 
to development of gastric cancer20，21）. Atrophic 
gastritis may progress to moderate or severe 
atrophic gastritis with advancing age. In a 10-
year prospective follow-up study that induced 
annual endoscopy, Sakaki et al.22） reported that the 
cumulative progression rate of atrophic patterns 
was 6% after 2 years, 22% after 4 years, 34% 
after 6 years, and 43% after 10 years in H. pylori-
positive patients. Our previous study３） showed that 
accurate endoscopic assessment of gastritis as per 
the updated Sydney System in conjunction with 
gastric fold findings and endoscopic assessment 
of atrophic gastritis are important indicators of H. 
pylori infection in the Japanese population. We also 
showed that the prevalence of atrophic gastritis 
increased and gastric acid secretion decreased with 
age in H. pylori-positive patients and that atrophic 
gastritis is extremely rare, regardless of age, in H. 
pylori-negative subjects23）. 
   The second recognizable characteristic of 
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endoscopic findings in H. pylori-positive young 
patients was nodularity. Nodular gastritis is an antral 
gastritis characterized endoscopically by an unusual 
small-granulated pattern, and the main histological 
feature is hyperplasia of lymphoid follicles with 
intense inflammatory cell infiltration in the propria 
lamina of the stomach24）. Nodular gastritis is often 
referred to as antral nodularity according to the 
updated Sydney System. Previous studies have 
shown that nodular gastritis is strongly associated 
with H. pylori infection in both children25） and 
adults26）. Our recent study indicates that nodular 
gastritis may be associated with gastric cancer of 
the corpus and may be a significant risk factor for 
diffuse-type gastric cancer13）. 
   Surprisingly, the high prevalence of atrophic 
change of the corpus evaluated by endoscopy 
(83.6%, 4 cases with severe atrophic gastritis) was 
noted in subjects with H. pylori-positive endoscopic 
findings. No atrophic change as evaluated by 
endoscopy was found in subjects with H. pylori-
negative findings. In addition, based on histological 
assessments of biopsy specimens, our study showed 
that both inflammation and atrophy of the corpus 
were frequently found in subjects with H. pylori-
positive endoscopic findings (more than moderate 
inflammation 76.1% and atrophy 34.3%). Among 
subjects less than 29 years old in this study, 
intestinal metaplasia was detected in 6 (9.0%) 
subjects with H. pylori-positive endoscopic findings. 
Histological corpus gastritis might progress to 
atrophy of the corpus with advancing age. Asaka 
et al.17） performed a 21 multi-center study in Japan 
and showed that atrophic gastritis was very high in 
H. pylori-positive young patients (38.5% in those 
less than 20 years, 58.5% in those 21-30 years). 
Our previous cross-sectional study also indicated 
that atrophic gastritis and decrease in gastric acid 
advances with age23）.Therefore, atrophic gastritis 
is strongly associated with H. pylori infection and 
age. Before the discovery of H. pylori, atrophic 
gastritis and intestinal metaplasia were linked to 
gastric cancer, especially intestinal-type cancer27）. 
Recently, H. pylori has been recognized as a risk 
factor for gastric cancer４，21）. We previously showed 
that H. pylori infection is strongly associated with 
gastric cancer and atrophic gastritis and that it might 
contribute to the pathogenesis of gastric cancer in 
young patients28）. Wong et al. 29） showed that the 
eradication of H. pylori significantly decreased 
development of gastric cancer in H. pylori carriers 
without precancerous lesions. Recent multiple 
studies also indicate that the H. pylori curative 
therapy decreases development of gastric cancer 
and improves atrophic gastritis10，11）. In this study, 
49 of 68 cases (72.1%) of H. pylori-positive patients 
received eradication treatment, of which 38 were 
successfully treated, 1 failed treatment, and 10 
were lost to follow-up. In 2017, gastric cancer was 
the second most common malignancy in male and 
the fourth most common malignancy in female 
populations, with 45,226 (29,745 males and 15,481 
females) gastric cancer related deaths30）. The 
incidence of gastric cancer increases with age. Thus, 
H. pylori should be cured as early as possible to 
prevent progression of atrophic gastritis.
   In general, gastric cancer is more common in 
males than in females, however no difference is 
found in young subjects28）. Previous studies indicate 
that atrophic gastritis and intestinal metaplasia are 
more common in males compared to females16，31）. 
We investigated the endoscopic and histologic 
findings between sexes in this study, and no 
significant difference was observed between male 
and female young subjects.
   There were several limitations to this study. First, 
this was a retrospective study. Second, disagreement 
of interpretation between a trained endoscopist and 
our three evaluators was found in several cases 
and a consensus needed to be reached by the three 
evaluators. One H. pylori-positive patient was 
diagnosed as having normal endoscopic findings 
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by retrospective evaluation; however, the trained 
endoscopist diagnosed this patient as a case of 
mild atrophic gastritis of the corpus. Third, biopsy 
specimens were obtained from two defined areas (the 
greater curvature of the antrum and corpus), and 
therefore the evaluation of histologic gastritis in this 
study may not be a comprehensive assessment of 
the whole stomach. Both inflammation and atrophy 
are diffuse changes and can be diagnosed by spot 
biopsy; however, intestinal metaplasia is a patchy 
change of gastric mucosa and multiple biopsy 
specimens or dye staining method are required 
for a reliable diagnosis. Finally, the diagnosis for 
H. pylori infection was performed by histologic 
examination using Giemsa or Gimenez staining. The 
sensitivity of this method for diagnosis of H. pylori 
infection is only 88%32）. 
   In conclusion, our present study demonstrates 
that the Kyoto classification is useful to diagnose 
both H. pylori infection and histologic gastritis 
based on endoscopic findings, and that prompt 
curative therapy for H. pylori is required to 
prevent development of gastric cancer especially 
considering the high prevalence of atrophic gastritis 
in H. pylori-positive young subjects in Japan. 
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